MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
FATE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Fate Therapeutics (FATE) Ownership - Who owns Fate Therapeutics?

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
161
Web
https://www.fatetherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
249.44M
P/E Ratio
N/A
Total Cash
174.82M
Projected Growth
N/A
Total Debt
76.79M
Revenue
6.32M
Risk (Beta)
3.70
Dividend Yield
N/A
Total Cash/Share
1.50
Total Debt/Equity
2.75
Revenue/Share
0.05 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
FATE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for FATE
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
161
Web
https://www.fatetherapeutics.com